Pipeline Programs↗
Distinct drugs in development (Preclinical–Phase 3)
Indications↗
Distinct diseases across all programs
Clinical Trials↗
All sponsored trials (all statuses)
Activity
Last 14 days
Study of Talabostat and Cisplatin in Advanced Melanoma
Study of Talabostat and Docetaxel in Advanced Non-Small Cell Lung Cancer
Trial of Talabostat and Gemcitabine in Patients With Stage IV Adenocarcinoma of the Pancreas
Study of Talabostat and Rituximab in Advanced Chronic Lymphocytic Leukemia (CLL)
Study of Talabostat in Advanced Melanoma
Details
Company Overview
—
Mkt Cap
—
Revenue
—
Cash
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)